Labshake search
Citations for TriLink BioTechnologies :
1 - 16 of 16 citations for Prostaglandin H2 Analog since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Molecular Biology 2021Quote: ... Modified UTP analogs were purchased from TriLink, Inc.
-
bioRxiv - Synthetic Biology 2021Quote: ... 6 mM Anti Reverse Cap Analog (TriLink BioTechnologies), and the template DNA ...
-
bioRxiv - Immunology 2022Quote: ... including an Anti-Reverse Cap Analog (ARCA, Trilink BioTechnologies), and chemically modified N1-methylpseudouridine-5’-triphosphate (Trilink BioTechnologies ...
-
bioRxiv - Genomics 2024Quote: ... 1 mM ATP or a modified ATP analog (Trilink, 2’-O-Methyladenosine-5’-Triphosphate ...
-
bioRxiv - Cancer Biology 2019Quote: ... and nucleotide analogs 8-oxo-dGTP and dPTP (TriLink Biotech) as described previously37,38 ...
-
bioRxiv - Immunology 2020Quote: ... Anti-Reverse Cap Analog (ARCA, Trilink Biotechnologies, San Diego, USA) was used for mRNA capping ...
-
bioRxiv - Genetics 2021Quote: ... mRNA was capped co-transcriptionally using CleanCap AG analog (TriLink Biotechnologies) resulting in a 5′ Cap 1 structure ...
-
bioRxiv - Molecular Biology 2022Quote: ... and mRNA was capped co-transcriptionally using CleanCap AG analog (TriLink Biotechnologies Cat ...
-
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian CancerbioRxiv - Cancer Biology 2020Quote: ... and the nucleotide analogs 8-oxo-dGTP and dPTP (TriLink Biotech). Six separate PCR reactions were performed in which the concentration of analogs and the number of cycles were varied to obtain a range of mutation frequencies ...
-
bioRxiv - Immunology 2022Quote: ... with 2.5 mM N1-Methylpseudouridine-5’-triphosphate nucleoside analog (TriLink BioTechnologies) instead of unmodified UTP ...
-
bioRxiv - Systems Biology 2023Quote: ... and co-transcriptional 5’ capping with the CleanCap AG analog (Trilink BioTechnologies Cat No. N-7113) to generate a 5’ Cap1 structure ...
-
bioRxiv - Genomics 2024Quote: ... and co-transcriptional 5’ capping with the CleanCap AG analog (Trilink BioTechnologies Cat No. N-7113) to generate a 5’ Cap1 structure ...
-
bioRxiv - Bioengineering 2020Quote: ... Oligonucleotides were synthesized by a custom Trimer Phosphoramidite mix for CDR H1 and CDR H2 (Twist Bioscience) and CDR H3 (Trilink Biotechnologies, Inc.) (Table S2) ...
-
bioRxiv - Molecular Biology 2023Quote: ... with complete substitution of uridine to 1- methylpseudouridine and CleanCap AG analog (N-1081 and N-7113, TriLink Biotechnologies).
-
bioRxiv - Evolutionary Biology 2021Quote: ... we used the following reaction mixture: 150nM each of the nucleotide analogs 8-oxodeoxyguanosine triphosphate (8-oxo-dGTP, Trilink Biotechnologies) and 6-(2-deoxy-beta-D-ribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-C] [1,2]oxazin-7-one triphosphate (dPTP ...
-
bioRxiv - Immunology 2020Quote: ... Capping of the IVT mRNAs was performed co-transcriptionally using the trinucleotide cap1 analog CleanCap (TriLink, San Diego, CA, USA). After DNase digestion ...